Official Journal of the Society of Cutaneous Oncology
Joined April 2023
- Tweets41
- Following15
- Followers13
- Likes23
New Editorial: Persuaded, Not Certain: Why I Voted Yes — reflections on the FDA advisory committee review of RP1 + nivolumab after PD-1 progression, and the uncertainty behind a difficult regulatory decision.
journalofcutaneousoncology.i…
#Replimune #RP1 #FDA
Hot off the press in Perspectives on the Science (JoCO):
"Nivolumab Plus Ipilimumab in Merkel Cell Carcinoma" delves into dual checkpoint blockade and its promising impact on MCC outcomes.
👉 Read more: journalofcutaneousoncology.i…
#MCC #Immunotherapy #NivoIpi #DermOnc #JoCO
New in Perspectives on the Science (JoCO):
"The Evolving Role of Circulating Tumor DNA in Merkel Cell Carcinoma" explores how ctDNA is reshaping disease monitoring, prognosis, and potentially guiding treatment.
🧬 Read the full piece: journalofcutaneousoncology.i…
#MCC #ctDNA #JoCO
Tumor-Infiltrating lymphocyte #TIL therapy is a new FDA-approved option for patients with advanced #melanoma. In this #JoCO editorial, the authors reflect on the recent approval of the first cellular therapy for melanoma.
doi.org/10.59449/joco.2024.0…
Is routine skin cancer screening recommended for all? Check out this Perspectives on the Science article to find out more: doi.org/10.59449/joco.2023.0…
#skincancer
Merkel Cell Carcinoma is a rare skin cancer with the potential for recurrence and poor patient outcomes. Check out this Perspectives on the Science article that examines the role of post-operative immunotherapy for MCC: doi.org/10.59449/joco.2023.0…
Moh's surgery is one option for patients with invasive melanoma. Check out this Perspectives on the Science article to read more about it: doi.org/10.59449/joco.2024.0…
Does more frequent surveillance imaging improve patient outcomes in stage III melanoma? Check out the Perspectives on the Science article by Kevin Emerick and @TheMillerLab doi.org/10.59449/joco.2024.0….
Is adjuvant anti-PD1 ready for the clinic for patients with Merkel Cell Carcinoma? Check out the latest #JoCO Perspectives on the Science.
journalofcutaneousoncology.i…
#MCC #Immunotherapy #Cancer
Journal of Cutaneous Oncology retweeted
Explore Mohs Micrographic Surgery and Immunotherapy in Non-Melanoma Skin Cancer with leading experts Dr. Miller @TheMillerLab and Dr.Patel!
Register now for Monday, June 26th at 7:00 PM ET: medlearninggroup.com/cme-pro…
#Virtual #CME #Immunotherapy #MedTwitter #MedLearningGroup
ALT Complementary Therapeutic Approaches: Mohs Micrographic Surgery and Immunotherapy in Non-Melanoma Skin Cancer
Journal of Cutaneous Oncology retweeted
Thx to Laura Ferris, Nikhi Khushalani, Kevin Emerick, Sonia Cohen, Sameer Gupta, Ryan Sullivan, @bosques12, @EmilyKimMed, @BhatiaS_MD, @MunTheLoon & @TheMillerLab for another great Journal Club discussion of the @USPSTF recs re: skin cancer screening
jamanetwork.com/journals/jam…
Journal of Cutaneous Oncology retweeted
David Miller & Sophia Shalhout with @MGHMedicine & @MassEyeAndEar, will be giving a session presentation on “StoryboardR: An R package and Shiny application designed to visualize real-world data from clinical patient registries” at #RMed2023. #Rstats ➡️ events.linuxfoundation.org/r…
ALT Below the R/Med logo there is text "StoryboardR" and "David Michael Miller, Oncologist at Massachusetts General Hospital" and ""Sophia Z. Shalhout Principal Investigator, Mass Eye and Ear/Harvard Medical School"
Journal of Cutaneous Oncology retweeted
You still have time to join us live from #ASCO23!
Learn and earn credit from social media. Watch the stream now.
Mission - Impossible to Possible: Using Immunotherapy for the Treatment of Nonmelanoma Skin Cancers. Watch and Earn Credit Now! #LiveCME #CME #MedEd #OncTwitter #ASCO23 Supported by an independent educational grant from Regeneron Pharmaceuticals, Inc. teapawt.net/i/broadcasts/1ynJOapPl…
Journal of Cutaneous Oncology retweeted
🎉 The excitement is building as we count down for our Complimentary Virtual CME/CNE Program on NMSC!
Join Dr. Miller @TheMillerLab and Dr. Patel TONIGHT at 7:30 PM EST!
Register Now: ow.ly/HZUo50OBUVO
#oncology #MedTwitter #VirtualEvent #CME #CNE #MedLearningGroup
ALT The Emerging Standard of Care: Immunotherapy in Non-Melanoma Skin Cancer
Journal of Cutaneous Oncology retweeted
Thanks @MedscapeLIVE for another fantastic event on #immunotherapy and #skincancer. Really enjoyed learning from @KYTsaiLab and Dr. Michael Migden. Great having the inimitable Dr. Michael Wong fielding questions on the real-time virtual forum.
📍 We have another sympo streaming on our social media channels today!
Learn & earn credit by participating online.
Simply follow us on Facebook, Twitter, YouTube or LinkedIn to view the sympo tonight. #ASCO23
Have questions? Tweet at us!
Register here: ms.spr.ly/6015ggvkX
Journal of Cutaneous Oncology retweeted
Excited for the upcoming #RMed2023. Always one of my favorite events of the year. Looking forward to presenting StoryboardR - An R Package and Shiny Application Designed to Visualize Real-World Data From Clinical Patient Registries with @SophiaShalhout.
#Rstats @r_medicine
Journal of Cutaneous Oncology retweeted
Looking forward to hearing from our esteemed panelists @KYTsaiLab and Dr. Michael Migden along with co-chair Dr. Michael K Wong in our upcoming @MedscapeLIVE event:
na.eventscloud.com/website/5…
It should make for a great discussion.
